- Seyyed Mohammad Kazemeyni
 - - Department of Urology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
- Mohammad Ali Sedighi
- - Department of Urology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
- Farid Dadkhah
- - Department of Urology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Hossein Hadi Nadooshan
- - Immunology Department, Faculty of Medicine, Tehran Medical Sciences University, Tehran, Iran
Received: 10/1/2003 Accepted: 10/1/2003 - Publisher : Avicenna Research Institute |
| Related Articles |
|
| Other Format |
|
|
|
Abstract
Male Infertility treatment has reached to prominent improvements in recent years by emergence of microinjection. In this method even with finding at least one spermatozoa, through Testicular Sperm Extraction (TESE), fertility would be possible. By such facilities, the treatment of non obstructive azoospermic men would be possible and finding of at least a few sperm from testis was signified. In order to predict the probability of retrieving spermatozoa from testis, different study was performed. Immune system and its role in production of antisperm antibody was considered in this study. Sperm antigens which appear at puberty are unfamiliar for immune system and their encounter with immune system stimulate and produce antisperm antibody (ASA). So, this study evaluated the relationship between antisperm antibodies in serum and semen of infertile men with outcome of testicular sperm extraction. This study included 94 azoospermic men who needed diagnostic biopsy or TESE. ASA was detected by indirect MAR test for IgG and IgA and the correlation between level of ASA and success rate of TESE were evaluated by statistic tests. The results showed that in men with positive TESE, level of IgG was more than negative one.(rspearman=0.360, p=0.000). In 40 men the result of MAR test was more than 10% and sperm found in samples of 34 men. So in this study the positive predictive value of antisperm IgG was 85% and its negative predictive value was 52%. By having the level of IgG in MAR test equal or more than 40%, its positive predictive value would be 100%. It is worthy to note that negative ASA does not predict the absence of spermatogenesis. In other word, negative test has not predictive value. Generally our results showed that antisperm antibody in serum and semen of azoosperic infertile men has a good prognosis for finding testis spermatozoa.
Keywords:
Male infertility, Antisperm antibody, Azoospermia, Microinjection, Predictor factor, Testicular sperm extraction To cite this article:References
- Tournaye H.,Devroey P., Liu J., Nagy Z., Lissens W., Van Steirteghem A. Microsurgical epididymal sperm aspiration and interacytoplasmic injection:
- Craft I., Tsirigotis M. Simplified recovery, preparation and cryopreservation of testicular spermatozoa. Hum Reprod.1995;1623-1627.
- Siber S.J.Quantitative analysis of testicular Biopsy. Fertil Steril.1981;36:480-485.
- Siber S.J. Sertoli cell-only syndrome. Hum Reprod.1996;11:229-233.
- Silber S.J. Normal pregnancies resulting from testicular sperm extraction and interacytoplasmic sperm injection for azoospermic due to maturation arrest. Fertil Steril.1996;66:110-117.
- Tournaye H., Verheyen G., Nagy P., Ubaldi F., Goossens A., Silber S.J., Van Steirteghem A.C., Devroey P. Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum Reprod.1997;12:80-86.
- Ezeh U. I., Moore H.D., Cooke I. D.Correlation of testicular sperm extraction with morphological, biophysical and endocrine profiles in men with azoospermia due to primary gonadal failure. Hum Reprod.1998;13:3066-3074.
- Jensen T.K., Andersson A.M., Hjollund N.H.I., et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab.1997;82:4059–4063.
- Pierik F.H., Vreeburg J.T., Stijnen T., De Jong F.H, Weber R.F.A. Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab. 1998;83:3110–3114.
- Sigrid V., Eckardstein M. S., Martin. Bergmann., Gerhard F., Weinbauer Paul Gassner, Andreas G., Schepers., Eberhard N. Serum Inhibin B in Combination with Serum Follicle-Stimulating Hormone (FSH) Is a More Sensitive Marker Than Serum FSH Alone for Impaired Spermatogenesis in Men, But Cannot Predict the Presence of Sperm in Testicular Tissue Samples . J Clin Endo Metab. 1999;84(7)2496-2501.
- Turek P.J. Infections, Immunology,and male infertility Clinics of north America.1999;10:435-470.